Global Polio Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

Scope of the Report:
This report focuses on the Polio Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.
The worldwide market for Polio Vaccine is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 1630 million US$ in 2023, from 1210 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Market Segment by Applications, can be divided into
Public
Private

There are 15 Chapters to deeply display the global Polio Vaccine market.
Chapter 1, to describe Polio Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Polio Vaccine, with sales, revenue, and price of Polio Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Polio Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Polio Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions